Related Experiment Video
Updated: May 22, 2026
Reverse Genetic Approach to Identify Regulators of Pigmentation using Zebrafish
Published on: March 1, 2022
Characterization of two novel small molecules targeting melanocyte development in zebrafish embryogenesis
1Laboratory of Chemical Genomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.
Abstract:
Melanocytes are pigment cells that are closely associated with many skin disorders, such as vitiligo, piebaldism, Waardenburg syndrome, and the deadliest skin cancer, melanoma. Through studies of model organisms, the genetic regulatory network of melanocyte development during embryogenesis has been well established. This network also seems to be shared with adult melanocyte regeneration and melanoma formation. To identify chemical regulators of melanocyte development and homeostasis, we screened a small-molecule library of 6000 compounds using zebrafish embryos and identified five novel compounds that inhibited pigmentation. Here we report characterization of two compounds, 12G9 and 36E9, which disrupted melanocyte development. TUNEL assay indicated that these two compounds induced apoptosis of melanocytes. Furthermore, compound 12G9 specifically inhibited the viability of mammalian melanoma cells in vitro. These two compounds should be useful as chemical biology tools to study melanocytes and could serve as drug candidates against melanocyte-related diseases.
Insights
Researchers screened 6000 compounds to find new regulators of melanocyte development. Two compounds, 12G9 and 36E9, were identified, disrupting melanocyte development and inducing apoptosis, with 12G9 showing melanoma cell inhibition.
Area of Science:
- Developmental Biology
- Cell Biology
- Pharmacology
Background:
- Melanocytes are crucial pigment cells implicated in various skin disorders, including vitiligo, piebaldism, Waardenburg syndrome, and melanoma.
- The genetic regulatory network governing melanocyte development is established in model organisms and appears conserved in adult regeneration and melanoma.
- Identifying chemical regulators is key to understanding melanocyte biology and disease.
Purpose of the Study:
- To discover novel small molecules that regulate melanocyte development and homeostasis.
- To characterize the effects of identified compounds on melanocyte biology.
- To evaluate the potential of these compounds as tools for research and therapeutic development.
Main Methods:
- Screening of a 6000-compound small-molecule library using zebrafish embryos to identify pigmentation inhibitors.
- Characterization of lead compounds, specifically 12G9 and 36E9, for their effects on melanocyte development.
- TUNEL assay to assess apoptosis induction in melanocytes.
- In vitro viability assays using mammalian melanoma cells.
Main Results:
- Five novel compounds inhibiting pigmentation were identified from the screen.
- Compounds 12G9 and 36E9 were characterized and found to disrupt melanocyte development.
- TUNEL assays confirmed that 12G9 and 36E9 induce melanocyte apoptosis.
- Compound 12G9 demonstrated specific inhibition of mammalian melanoma cell viability in vitro.
Conclusions:
- Compounds 12G9 and 36E9 are effective chemical tools for studying melanocyte development and homeostasis.
- These compounds show potential as therapeutic candidates for melanocyte-related diseases, including melanoma.
- Further investigation into their mechanisms of action and efficacy is warranted.
